Clinical manifestations, causative pathogens and treatment outcomes of patients with bacterial meningitis at a general hospital in eastern Thailand

Main Article Content

Natenoi Chalee
Wichai Santimaleeworagun
Kawin Duangmee
Juthathip Suphanklang


Bacterial meningitis is a severe infection with significant morbidity and mortality. This study aimed to analyze causative pathogens, empirical therapy, antibiotic susceptibility, neurological sequelae and mortality rate in patients with bacterial meningitis. The study design was a retrospective, descriptive study. Patient eligibility criteria were the following: individuals diagnosed with bacterial meningitis according to the International Classification of Diseases (ICD)-10 codes from January 2014 to December 2017 at Sa Kaeo Crown Prince Hospital. A total of 99 patients with bacterial meningitis were identified, and 29% exhibited the classic triad (fever, drowsiness and neck stiffness). The causative pathogens were detected from blood or cerebrospinal fluid (CSF) in 40% and 6.1% of patients, respectively. The most common pathogens were Streptococcus spp. (10 patients), followed by Streptococcus suis (7 patients) and group D streptococcus (7 patients). Empirical therapy with monotherapy was mainly either ceftriaxone or cefotaxime (69.7%); however, the cephalosporin-resistant strain was 20.8%. Clinical outcomes included the 14-day mortality rate and neurological sequelae in 3% and 26.3% of patients, respectively. Pneumonia, septic shock and low CSF glucose concentration were significantly associated with unfavorable outcomes. Consequently, the most causative pathogen was Streptococcus spp., which was the third-generation cephalosporin-resistant strain. Third-generation cephalosporins plus vancomycin should be considered as an empirical therapy regimen.


Download data is not yet available.

Article Details

Health sciences


Aronin, S. I., Peduzzi, P., and Quagliarello, V. J. (1998). Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Annals of Internal Medicine, 129(11), 862-869.

Brouwer, M. C., McIntyre, P., Prasad, K., and van de Beek, D. (2015). Corticosteroids for acute bacterial meningitis. The Cochrane Database of Systematic Reviews, (9), CD004405.

Chang, B., Wada, A., Hosoya, M., Oishi, T., Ishiwada, N., Oda, M., Sato, T., Terauchi, Y., Okada, K., Nishi, J., Akeda, H., Kamiya, H., Ohnishi, M., Ihara, T., and Japanese Invasive Disease Study, G. (2014). Characteristics of group B streptococcus isolated from infants with invasive infections: a population-based study in Japan. Japanese Journal of Infectious Diseases, 67(5), 356-360.

Chang, C. J., Chang, W. N., Huang, L. T., Huang, S. C., Chang, Y. C., Hung, P. L., Tasi, C. Y., Lu, C. H., Cheng, B. C., Lee, P. Y., and Chang, H. W. (2003). Neonatal bacterial meningitis in southern Taiwan. Pediatric Neurology, 29(4), 288-294.

Chotmongkol, V., and Techoruangwiwat, C. (2000). Community acquired-bacterial meningitis in adults. The Southeast Asian Journal of Tropical Medicine and Public Health, 31(3), 506-508.

Chusri, S., Sakarunchai, I., Kositpantawong, N., Panthuwong, S., Santimaleeworagun, W., Pattharachayakul, S., Singkhamanan, K., and Doi, Y. (2018). Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant Acinetobacter baumannii. International Journal of Antimicrobial Agents, 51(4), 646-650.

De Gans, J., and van de Beek, D., (2002). Dexamethasone in adults with bacterial meningitis. The New England Journal of Medicine, 347(20), 1549-1556.

De Maria Ugalde-Mejia, L., Morales, V. A., Cardenas, G., and Soto-Hernandez, J. L. (2018). Adult patients with pneumococcal meningitis at a neurosurgical neurologic center: different predisposing conditions? World Neurosurg, 110, e642-e647.

Dejsirilert, S., Tienkrim, S., Ubonyaem, N., Sawanpanyalert, P., Aswapokee, N., and Suankratay, C. (2009). National antimicrobial resistance surveillance among clinical isolates of Streptococcus pneumoniae in Thailand. Journal of the Medical Association of Thailand, 92(4), S19-S33.

Fang, C. T., Chen, Y. C., Chang, S. C., Sau, W. Y., and Luh, K. T. (2000). Klebsiella pneumoniae meningitis: timing of antimicrobial therapy and prognosis. Quarterly Journal of Medicine, 93(1), 45-53.

Feldmann, W. E. (1977). Relation of concentrations of bacteria and bacterial antigen in cerebrospinal fluid to prognosis in patients with bacterial meningitis. Journal of the Medical Association of Thailand, 296(8), 433-435.

Fitch, M. T., and van de Beek, D. (2007). Emergency diagnosis and treatment of adult meningitis. The Lancet. Infectious Diseases, 7(3), 191-200.

Fongcom, A., Pruksakorn, S., Netsirisawan, P., Pongprasert, R., and Onsibud, P. (2009). Streptococcus suis infection: a prospective study in northern Thailand. The Southeast Asian Journal of Tropical Medicine and Public Health, 40(3), 511-517.

Fongcom, A., Pongprasert, R., and Punchaburi, B. (2002). Streptococcus suis infection an important underdiagnosed disease in Lamphun, northern Thailand. Bulletin of the Department of Medical Services, 27, 208-273.

Fuentes-Antras, J., Ramirez-Torres, M., Osorio-Martinez, E., Lorente, M., Lorenzo-Almoros, A., Lorenzo, O., and Gorgolas, M. (2019). Acute community-acquired bacterial meningitis: update on clinical presentation and prognostic factors. The New Microbiologica, 41(4), 81-87.

Isea-Pena, M. C., Sanz-Moreno, J. C., Esteban, J., Fernandez-Roblas, R., and Fernandez-Guerrero, M. L. (2013). Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae. Infection, 41(5), 935-939.

Khwannimit, B., Chayakul, P., and Geater, A. (2004). Acute bacterial meningitis in adults: a 20 year review. The Southeast Asian Journal of Tropical Medicine and Public Health, 35(4), 886-892.

Kourbeti, I. S., Vakis, A. F., Ziakas, P., Karabetsos, D., Potolidis, E., Christou, S., and Samonis, G. (2015). Infections in patients undergoing craniotomy: risk factors associated with post-craniotomy meningitis. Journal of Neurosurgery, 122(5), 1113-1119.

Kurtaran, B., Kuscu, F., Ulu, A., Inal, A. S., Komur, S., Kibar, F., Cetinalp, N. E., Ozsoy, K. M., Arslan, Y. K., Yilmaz, D. M., Aksu, H., and Tasova, Y. (2018). The causes of postoperative meningitis: the comparison of gram-negative and gram-positive pathogens. Turkish Neurosurgery, 28(4), 589-596.

Lovera, D., and Arbo, A. (2005). Risk factors for mortality in Paraguayan children with pneumococcal bacterial meningitis. Tropical Medicine & International Health, 10(12), 1235-1241.

Lu, C. H., Chang, W. N., and Chang, H. W. (2000). Adult bacterial meningitis in southern Taiwan: epidemiologic trend and prognostic factors. Journal of The Neurological Sciences, 182(1), 36-44.

Lu, C. H., Chang, W. N., and Chang, H. W. (2001). Streptococcal meningitis in adults: therapeutic outcomes and prognostic factors. Clinical Neurology and Neurosurgery, 103(3), 137-142.

Mook-Kanamori, B. B., Geldhoff, M., van der Poll, T., and van de Beek, D. (2011). Pathogenesis and pathophysiology of pneumococcal meningitis. Clinical Microbiology Reviews, 24(3), 557-591.

Nathan, N., Borel, T., Djibo, A., Evans, D., Djibo, S., Corty, J. F., Guillerm, M., Alberti, K. P., Pinoges, L., Guerin, P. J., and Legros, D. (2005). Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study. Lancet, 366(9482), 308-313.

Opartpunyasarn, P., and Suwanpimolkul, G. (2019). Bacterial meningitis: etiologies, drug susceptibilities and mortality rate at a university hospital in Thailand. The Southeast Asian Journal of Tropical Medicine and Public Health, 50(1), 155-161.

Prasad, K., Kumar, A., Gupta, P. K., and Singhal, T. (2007). Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis. Cochrane Database of Systematic Reviews, 4, CD001832.

Sadarangani, M. (2018). Protection against invasive infections in children caused by encapsulated bacteria. Frontiers in Immunology, 9, 2674.

Santimaleeworagun, W., Jangkong, N., Petchhouyluek, K., Leawsrivilai, N., Suwanraksa, W., and Buapool, W. (2019). Prevalence of causative bacteria and clinical outcomes among patients with meningitis at a regional central hospital in Thailand. Science, Engineering and Health Studies, 13(3), 109-118.

Satar, M., Arisoy, A. E., and Celik, I. H. (2018). Turkish Neonatal Society guideline on neonatal infections-diagnosis and treatment. Turkish Archives of Pediatrics, 53(1), S88-S100.

Schut, E. S., Lucas, M. J., Brouwer, M. C., Vergouwen, M. D., van der Ende, A., and van de Beek, D. (2012). Cerebral infarction in adults with bacterial meningitis. Neurocrit Care, 16(3), 421-427.

Suphanklang, J., Santimaleeworagun, W., Thunyaharn, S., and Traipattanakul, J. (2017). Pneumococcal meningitis at a Thai hospital over a 10-year period: clinical outcomes, serotypes, and antimicrobial susceptibility patterns. The Southeast Asian Journal of Tropical Medicine and Public Health, 48(6), 1281-1289.

Tauber, M. G., Khayam-Bashi, H., and Sande, M. A. (1985). Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. The Journal of Infectious Diseases, 151(3), 528-534.

Tenforde, M. W., Meintjes, G., Mokomane, M., Harrison, T. S., Mine, M., and Jarvis, J. N. (2019). Low-cerebrospinal fluid white cell counts and mortality in HIV-associated pneumococcal meningitis. AIDS, 33(9), 1539-1541.

Tonsanoi, P. (2018). A study of Streptococcus suis infection: a cases of in-patients at Sa Kaeo crown prince hospital. Chula Journal of Medicine, 31, 50-65.

Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., and Whitley, R. J. (2004). Practice guidelines for the management of bacterial meningitis. Clinical Infectious Diseases, 39(9), 1267-1284.

van de Beek, D., Cabellos, C., Dzupova, O., Esposito, S., Klein, M., Kloek, A. T., Leib, S. L., Mourvillier, B., Ostergaard, C., Pagliano, P., Pfister, H. W., Read, R. C., Sipahi, O. R., and Brouwer, M. C. (2016). ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clinical Microbiology and Infection, 22(3), S37-S62.

van de Beek, D., de Gans, J., Spanjaard, L., Weisfelt, M., Reitsma, J. B., and Vermeulen, M. (2004). Clinical features and prognostic factors in adults with bacterial meningitis. The New England Journal of Medicine, 351(18), 1849-1859.

van de Beek, D., de Gans, J., Tunkel, A. R., and Wijdicks, E. F. M. (2006). Community-acquired bacterial meningitis in adults. The New England Journal of Medicine, 354(1), 44-53.

World Health Organization. (2007). Standardized treatment of bacterial meningitis in Africa in epidemic and non-epidemic situations. [Online URL: https://apps.] accessed on 12 April, 2020.